By comparing to mice fed with normal diet and E. coli gavage, both L. j and FMD treatments markedly retarded tumor growth (Fig. 4h, i), as well as inducing increases anti-cancer immune responses, in particular in CD45+ and CD8+ T cells (Fig. 4j, k). Here, PTPRC is linked to cancer.